1. Yi Zhang 1*, Moyi Chen 1, Dongsheng Huang * , Huali Gu 1, You Yi 1, Xue Meng 1.Correlation between ARID1B gene mutation (p.A460, p.V215G) and prognosis of high-risk refractory neuroblastom.Cell Biology Internation.2023.2.1-13.SCI |
2. Didi Fabian(外)*,张谊#,王一卓#,et al..The Global Retinoblastoma Outcome Study: a prospective, cluster-based analysis of 4064 patients from 149 countries.Lancet Global Health.2022.10(8).e1128-1140.SCI |
3. 王一卓#,张谊#,黄东生*,史季桐,马建民,李彬,顼晓琳,周燕,顾华丽.Clinical characteristics, treatment and prognosis of children with unilateral retinoblastoma and intracranial segment of retrobulbar optic nerve invasion.BMC Opthalmology.2021.31(38).38-46.SCI |
4. 张谊,王一卓#,黄东生*,马建民,张伟令,顾华丽,周燕,易优,张品伟.Correlation between family RB1 gene pathogenic variant with clinical features and prognosis of retinoblastoma under 5 years old.Disease Markers.2021.2021(7).1-10.SCI |
5. 孟雪,黄东生,张谊*. 儿童肝母细胞瘤伴瘤栓的研究进展 .国际儿科学杂志.2020.47(5).344-348 .核心期刊 |
6. 蔡耀华,黄东生,张谊*.儿童肝母细胞瘤的不同诊疗策略.中国小儿血液与肿瘤杂志.2020.25(1).53-56.核心期刊 |
7. 张谊,张伟令,黄东生*,王一卓,孟雪.恶性实体瘤继发白血病患儿的诊疗及预后.中华妇幼临床医学杂志电子版.2020.16(1).67-73.核心期刊 |
8. Yi Zhang#,Wei-Ling Zhang#,Dong-Sheng Huang*,Yi-Zhuo Wang | Hui-Min Hu | Yan-Yan Mei | Tian Zhi.prognostic factors in children with head and neck rhabdomyosarcoma:A 12-year retrospective study .Brain and Behavior .2020.6(8). e01697-01704 .SCI |
9. 张谊,张伟令,黄东生,王一卓,胡慧敏,李颂,孟雪.高危头颈部横纹肌肉瘤临床特征及预后分析 .中华实用儿科临床杂志.2020.35(3).193-196 .核心期刊 |
10. 王嘉欣 黄东生 张谊*.儿童肝母细胞瘤AFP、Nrf2和β-catenin表达对指导治疗的意义 .中国小儿血液与肿瘤杂志 .2020.25(2).118-122.核心期刊 |
11. GlobalRetinoblastomaStudyGroup,Ido didi Fabian#*,Yi Zhang#, Yizhuo Wang#..Global Retinoblastoma Presentation and Analysis By National Income Level.JAMA Oncology.2020.6(5).685-695.SCI |
12. 张谊,张伟令,黄东生,.儿童头颈部横纹肌肉瘤98李生存情况分析.中华全科医师杂志.2019.18(7).663-667.核心期刊 |
13. 张谊,黄东生*,张伟令,王一卓,易优,韩思雨,张品伟,高亚楠,孟雪,高淇然,刘婷婷.IN1基因表达与儿童肝母细胞瘤临床特点及预后的相关性研究.中华实用儿科临床杂志.2019.34(15).36-39.核心期刊 |
14. 万芳,张谊*,李梅.儿童小细胞未分化型肝母细胞瘤与肝恶性横纹肌样瘤的鉴别.中国小儿血液与肿瘤杂志.2019.24(3).166-168.核心期刊 |
15. ⑺ 张谊#,张伟令,黄东生*,王一卓,洪亮,易优,胡慧敏,李静,韩涛,周燕,李凡.4期神经母细胞瘤伴有骨髓转移的治疗疗效及预后分析.中国小儿血液肿瘤杂志.2018.23(2).69-71..核心期刊 |
16. 张谊#,张伟令,黄东生*,洪亮,杜燕燕,支天,韩涛,易优.43例4期神经母细胞瘤初期化疗疗效及长期生存的相关性分析.国际儿科学杂志.2018.45(7).557-560.核心期刊 |
17. 张谊#,张伟令,黄东生*,韩涛,支天,李静,易优,文圆,梅妍妍,杜燕燕.5岁以上神经母细胞瘤3期或4期患儿临床疗效及预后分析.中华全科医师杂志.2017.16(1).48-52.核心期刊 |
18. ZHANGYI#,HUANG Dongsheng*, ZHANG WEILING, HAN TAO, HU HUIMIN, ZHI TIAN, YI YOU.study on the experience on clinical characteristics and the outcome of pediatric hepatoblastoma .Bimedical Research.2017.28(16).7215-7321.SCI |
19. YI ZHANG#, DONGSHENG Huang*, Weiling Zhang, YIZHUO WANG,YAN ZHOU, PINWEI ZHANG,TAO HAN,JIAN MIN MA,JITONG SHI, XIN GE.A long follow up of a case of bilateral tetinoblastoma underwent globe preseving therapy and had metatasis after 6.5 years..IJO.2017.10(10).1624-1627.SCI |
20. 张谊#,黄东生*,张玉洁,张伟令,王一卓,洪亮.指导医学本科生进行临床科研的研究体会.继续医学教育.2016.30(9).71-72.核心期刊 |
21. ZHANGYI#,HUANG Dongsheng*, ZHANG WEILING, HAN TAO, HU HUIMIN, ZHI TIAN, YI YOU.Clinical characteristics of infant neuroblastoma and a summary of treatment outcome.Oncology Letters.2016.12(11).5356-5362.SCI |
22. YI ZHANG#,ZHANG WEILING#,HUANG DONGSHENG*, LIPING CHEN, YOU YI, PINWEI ZHANG, AIPING LIU, TIAN ZHI.A single-center retrospective study of pediatric hepatoblastoma.Oncology Letters.2016.12(10).3919-3925.SCI |
23. 张谊#,张伟令,黄东生*,陈丽萍,易优,李静,胡慧敏,支天.3岁以上肝母细胞瘤患儿的临床特点及预后分析.中华实用儿科临床杂志.2016.31(15).1169-1171.核心期刊 |
24. 张谊#,张伟令,黄东生*,韩涛,支天,李静,易优,文圆,梅妍妍,杜燕燕.5岁以上神经母细胞瘤患者的临床特点及疗效分析.中国当代儿科杂志.2016.18(12).1217-1221.核心期刊 |
25. 张谊#,黄东生,唐锁勤*.survivin基因靶向药物研究进展.中国小儿血液与肿瘤杂志.2015.20(5)..276-280.核心期刊 |
26. ZHANG WEILING#,ZHANG YI#, HUANG DONGSHENG, HAN TAO, YI ZHOU, ZHI TIAN, LI JING.High dose chemotherapy combined with autologous peripheral blood stem cell transplantation in children with advanced malignant solid tumors: A retrospective analysis of 38 cases.Oncology Letters.2015.10(1).1047-1053.SCI |
27. 张谊#,张伟令,黄东生*,张玉洁.南亚医学留学生儿科学教育教学管理初探.医学信息.2015.6(4).12.核心期刊 |
28. 张谊,黄东生.儿童肝母细胞瘤化疗治疗.国际儿科学杂志.2015.42(5).553-558.核心期刊 |
29. 张谊,黄东生.儿童肝母细胞瘤的诊断以及临床分型标准.中国小儿血液与肿瘤杂志.2015.20(4)..170-172.核心期刊 |
30. 张谊#,张伟令,陈丽萍,易优,张品伟,刘爱萍,支天,黄东生*.儿童 IV 期肝母细 胞瘤 52 例临床诊疗经验.中华实用儿科临床杂志.2015.30(23).1809-1811.核心期刊 |
31. 张谊#,张伟令,黄东生*,王一卓,洪亮,朱霞,刘爱萍,支天,胡慧敏.自体外周血 造血干细胞移植治疗儿童晚期恶性实体瘤 38 例.中国当代儿科杂志.2014.16(2).124-128.核心期刊 |
32. 张谊#,张伟令,黄东生*,王一卓,胡慧敏,洪亮,支天,秦静,陈丽萍.眼眶恶性嗜酸 性肉芽肿 15 例临床特点及疗效分析.中华实用儿科临床杂志.2014.29(15).1158-1160.核心期刊 |
33. ZHANG YI#,ZHANG WEILING ,HUANG DONGSHENG, HU HUIMIN, HAN TAO, ZHI TIAN.Clinical effectiveness of multimodality treatment advanced pediatric hepatoblastoma.Eur Rev Med Pharmacol Sci.2014.18(7).1018-1026.SCI |
34. 张谊#,黄东生*.全身奥曲肽显像在神经母细胞瘤的临床应用初探:附 14 例报告.临床儿科学杂志.2013.31(11).1050-1053.核心期刊 |
35. 张谊#,张伟令,黄东生*,呙芳,韩涛.儿童横纹肌肉瘤综合治疗疗效观察.国际儿科学杂志.2013.40(2).201-203.核心期刊 |
36. 张谊#,张伟令,黄东生*,王一卓,洪亮,李静,胡慧敏,周燕.参芪扶正 注射液在眼外期视网膜母细胞瘤中的应用.中国小儿血液与肿瘤杂志.2013.18(5).214-216.核心期刊 |
37. ZHANGYI#,HUANG Dongsheng*, ZHANG WEILING, HAN TAO, HU HUIMIN, ZHI TIAN, YI YOU.Clinical Efficacy and Prognosis Factors for Advanced Hepatoblastoma in Children: A 6-year Retrospective Study.Asian Pac J Cancer Prev.2013.14(8).4583-4589.SCI |